Skado medis - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 4,867,098 | 6,517,156 | 5,644,024 | 6,517,161 | 7,767,458 | 8,708,953 | 6,615,052 | 6,893,240 |
| Profit before tax | 100,062 | 176,529 | 76,887 | 193,082 | 569,072 | 717,786 | 403,330 | 45,529 |
| Net profit | 76,653 | 143,781 | 64,681 | 162,295 | 481,631 | 610,812 | 321,653 | 35,925 |
| Equity | 496,063 | 459,865 | 489,246 | 591,541 | 1,049,172 | 1,555,357 | 1,759,010 | 1,677,289 |
| Liabilities | 1,336,131 | 837,924 | 1,420,102 | 1,902,313 | 1,758,895 | 1,269,437 | 1,202,485 | 911,409 |
| Non-current assets | 554,353 | 476,468 | 672,795 | 628,428 | 588,920 | 656,062 | 495,942 | 387,170 |
| Current assets | 1,325,574 | 971,389 | 1,531,564 | 2,155,176 | 2,442,703 | 2,398,431 | 2,648,921 | 2,341,474 |
| Total assets | 1,879,927 | 1,447,857 | 2,204,359 | 2,783,604 | 3,031,623 | 3,054,493 | 3,144,863 | 2,728,644 |
|
Taxes paid
|
||||||||
| Social insurance contributions | - | - | - | - | - | 361,169 | 389,861 | 470,313 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +43.5% | +33.9% | -13.4% | +15.5% | +19.2% | +12.1% | -24.0% | +4.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 4.1% | 9.9% | 2.9% | 5.8% | 15.9% | 20.0% | 10.2% | 1.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 15.5% | 31.3% | 13.2% | 27.4% | 45.9% | 39.3% | 18.3% | 2.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.6% | 2.2% | 1.1% | 2.5% | 6.2% | 7.0% | 4.9% | 0.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 2.1% | 2.7% | 1.4% | 3.0% | 7.3% | 8.2% | 6.1% | 0.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.7 | 1.8 | 2.9 | 3.2 | 1.7 | 0.8 | 0.7 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 88,359 | 112,689 | 94,991 | 97,757 | 128,211 | 113,226 | 66,151 | 66,925 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Skado medis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-12 | 2026-05-13 | 30.12 |
| 2026-05-06 | 2026-05-11 | 30.05 |
| 2025-02-19 | 2025-02-19 | 5.91 |
Skado medis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-21 | 2026-02-27 | 28.01 |
| 2026-02-18 | 2026-02-20 | 19793.01 |
| 2026-01-15 | 2026-01-19 | 43.78 |
| 2026-01-14 | 2026-01-14 | 33964.17 |
| 2025-12-17 | 2025-12-18 | 26293.78 |
| 2025-09-26 | 2025-10-18 | 0.17 |
| 2025-09-25 | 2025-09-25 | 665.53 |
| 2025-09-23 | 2025-09-24 | 665.19 |
| 2025-09-19 | 2025-09-22 | 664.34 |
| 2025-09-14 | 2025-09-14 | 4043.26 |
| 2025-09-13 | 2025-09-13 | 4042.21 |
| 2025-09-12 | 2025-09-12 | 4098.41 |
| 2025-09-10 | 2025-09-11 | 25686.07 |
| 2025-08-13 | 2025-08-14 | 24721.46 |
| 2024-10-10 | 2024-10-13 | 3709.55 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Skado medis, UAB (code 300016580) is a Private Limited Liability Company engaged in the manufacture of wooden prefabricated buildings and structures. In 2025, the latest financial year, the company generated €6.89M in revenue, up 4.2% year on year, while net profit declined to €35.9K from €321.7K in 2024 and €610.8K in 2023. This left a net profit margin of 0.5%, indicating a much weaker profitability profile than in the previous two years. The 2023–2025 revenue trend shows a drop from €8.71M in 2023 to €6.62M in 2024, followed by a modest recovery in 2025. On the balance sheet, total assets decreased to €2.73M in 2025 from €3.14M a year earlier, while equity stood at €1.68M and liabilities at €911.4K. The equity ratio was 61.5% and debt-to-equity 0.54, suggesting a relatively solid capital structure. Asset turnover was 2.53x. Productivity indicators for 2025 show revenue per employee of €66.9K and profit per employee of €349.